This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fung-Tomc, J. C.
Right arrow Articles by Bonner, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fung-Tomc, J. C.
Right arrow Articles by Bonner, D. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2000, p. 1377-1380, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Comparative Killing Rates of Fluoroquinolones and Cell Wall-Active Agents

Joan C. Fung-Tomc,* Elizabeth Gradelski, Lourdes Valera, Benjamin Kolek, and Daniel P. Bonner

Department of Microbiology, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492

Received 8 October 1999/Returned for modification 24 November 1999/Accepted 11 February 2000

Killing rates of fluoroquinolones, beta -lactams, and vancomycin were compared against Enterobacteriaceae, Staphylococcus aureus, pneumococci, streptococci, and Enterococcus faecalis. The times required for fluoroquinolones to decrease viability by 3 log10 were 1.5 h for Enterobacteriaceae, 4 to 6 h for staphylococci, and >= 6 h for streptococci and enterococci. Thus, the rate of killing by fluoroquinolones is organism group dependent; overall, they killed more rapidly than beta -lactams and vancomycin.


* Corresponding author. Mailing address: Bristol-Myers Squibb Company, Department of Microbiology-104, 5 Research Pkwy., Wallingford, CT 06492. Phone: (203) 677-6370. Fax: (203) 677-6771. E-mail: fungtomj{at}bms.com.


Antimicrobial Agents and Chemotherapy, May 2000, p. 1377-1380, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Wiuff, C., Andersson, D. I. (2007). Antibiotic treatment in vitro of phenotypically tolerant bacterial populations. J Antimicrob Chemother 59: 254-263 [Abstract] [Full Text]  
  • Chung, P., McNamara, P. J., Campion, J. J., Evans, M. E. (2006). Mechanism-Based Pharmacodynamic Models of Fluoroquinolone Resistance in Staphylococcus aureus.. Antimicrob. Agents Chemother. 50: 2957-2965 [Abstract] [Full Text]  
  • Wiuff, C., Zappala, R. M., Regoes, R. R., Garner, K. N., Baquero, F., Levin, B. R. (2005). Phenotypic Tolerance: Antibiotic Enrichment of Noninherited Resistance in Bacterial Populations. Antimicrob. Agents Chemother. 49: 1483-1494 [Abstract] [Full Text]  
  • Regoes, R. R., Wiuff, C., Zappala, R. M., Garner, K. N., Baquero, F., Levin, B. R. (2004). Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment Regimens. Antimicrob. Agents Chemother. 48: 3670-3676 [Abstract] [Full Text]  
  • Gradelski, E., Kolek, B., Bonner, D., Fung-Tomc, J. (2002). Bactericidal mechanism of gatifloxacin compared with other quinolones. J Antimicrob Chemother 49: 185-188 [Abstract] [Full Text]  
  • Gradelski, E., Valera, L., Bonner, D., Fung-Tomc, J. (2001). Synergistic Activities of Gatifloxacin in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa and Related Species. Antimicrob. Agents Chemother. 45: 3220-3222 [Abstract] [Full Text]  
  • Venezia, R. A., Domaracki, B. E., Evans, A. M., Preston, K. E., Graffunder, E. M. (2001). Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother 48: 375-381 [Abstract] [Full Text]